NK Cell Therapy for Solid Tumors from China
NK cell therapy for solid tumors involves natural killer cells from peripheral blood that are cytokine-activated and expanded for adoptive transfer in cancer immunotherapy. These modified cell cultures are classified under tariff item 3002.51.00 as cell therapy products.
Duty Rate — China → Canada
0%
Import Tips
• Document the activation and expansion of NK cells to support classification under 3002.51.00
• Ensure the product is not classified as a vaccine or other biological product
• Verify compliance with Canadian regulations for adoptive cell therapy